AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway
Article in PLOS ONE (April 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Article in PLOS ONE (April 2024)
Article in Medical Gas Research (March 2024)
Article in TrAC Trends in Analytical Chemistry (November 2023)